Abbott Laboratories (ABTT34)
BOV
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 74.44B | 73.79B | 73.35B | 72.09B | 73.21B | 72.47B | 73.02B | 74.36B |
流動資産合計 | 25.22B | 24.38B | 23.51B | 22.66B | 22.67B | 22.38B | 23.12B | 23.8B |
現金および同等物 | 9.88B | 9.16B | 7.84B | 6.71B | 6.9B | 6.28B | 6.99B | 7.56B |
非流動資産合計 | 58.38B | 58.7B | 59.3B | 58.98B | 60.7B | 60.2B | 60.13B | 61.18B |
負債合計 | 37.53B | 36.56B | 35.95B | 34.4B | 34.39B | 33.42B | 33.46B | 34.33B |
流動負債合計 | 15.49B | 14.53B | 14.35B | 13.04B | 13.84B | 14.02B | 13.76B | 14.9B |
非流動負債合計 | 36.57B | 36.65B | 36.16B | 35.43B | 34.15B | 31.98B | 32.26B | 31.61B |
普通株 | 24.71B | 24.49B | 24.61B | 24.73B | 24.87B | 24.73B | 24.86B | 25.02B |
留保所得 | 35.26B | 35.87B | 36.36B | 36.92B | 37.55B | 38.01B | 38.35B | 39.06B |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 52.67B | 76.25B | 67.17B | 67.89B | 72.55B | 75.2B | 74.44B | 73.21B |
流動資産合計 | 26.78B | 20.15B | 14.63B | 15.67B | 20.44B | 24.24B | 25.22B | 22.67B |
現金および同等物 | 18.62B | 9.41B | 3.84B | 3.86B | 6.84B | 9.8B | 9.88B | 6.9B |
非流動資産合計 | 20.72B | 31.1B | 30.72B | 31.3B | 33B | 36.02B | 36.91B | 38.83B |
負債合計 | 31.95B | 45.15B | 36.45B | 36.59B | 39.55B | 39.17B | 37.53B | 34.39B |
流動負債合計 | 6.66B | 8.91B | 9.01B | 10.86B | 11.91B | 13.11B | 15.49B | 13.84B |
非流動負債合計 | 45.97B | 63.45B | 46.8B | 42.38B | 46.17B | 42.84B | 36.57B | 34.15B |
総資本 | 20.72B | 31.1B | 30.72B | 31.3B | 33B | 36.02B | 36.91B | 38.83B |
普通株 | 13.03B | 23.21B | 23.51B | 23.85B | 24.15B | 24.47B | 24.71B | 24.87B |
留保所得 | 25.57B | 23.98B | 24.56B | 25.85B | 27.63B | 31.53B | 35.26B | 37.55B |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約